MedTrace Logo

Zinc Incorporated Bovine Derived- Hydroxyappatite Xenograft in Immediately Placed Implant

NCT07187609 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 16

Last updated 2025-09-23

No results posted yet for this study

Summary

The aim of this study is to evaluate Clinical and radiographic effect of zinc incorporated bovine derived hydroxyapatite xenograft and bovine hydroxyapatite xenograft alone for immediately placed implant

Conditions

  • Implant
  • Zinc Status

Interventions

PROCEDURE

Immediate implant with bovine drived hydroxyapatite xenograft.

patients will undergo immediate implant with bovine drived hydroxyapatite xenograft.

PROCEDURE

immediate implant with zinc incorporated bovine drived hydroxyapatite xenograft

patients will undergo immediate implant with zinc incorporated bovine drived hydroxyapatite xenograft

Sponsors & Collaborators

  • Suez Canal University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
21 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-08-13
Primary Completion
2025-10-08
Completion
2026-11-08

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07187609 on ClinicalTrials.gov